Abstract:Recent clinical observations suggest that viral infection/reactivation may contribute to the development of idiopathic pulmonary fibrosis in susceptible hosts. Viral gene therapy using adenoviral vectors in the lung is limited by immune response directed against the viral vector and/or its foreign gene. We therefore examined the effects of adenoviral vector (E1, E3 deleted) on the course of bleomycin-induced lung injury/fibrosis in mice.MethodsAdenoviral vectors (native and UV-inactivated) expressing luciferase, β-galactosidase, or a human gene were administered intratracheally (IT; 109 PFU/animal) to mice 2 days after bleomycin (4 U/kg IT). Animals were assessed for mortality, lung inflammation (bronchoalveolar lavage [BAL] cell counts and differential), vascular permeability (BAL protein levels) and fibrosis (lung hydroxyproline) over the next 28 days.ResultsCombined bleomycin/adenoviral vector administration caused a 3-fold increase in 28 day mortality compared with bleomycin alone (20% to 60%; n = 20/group). The excess mortality was completely abrogated by substituting a UV-inactivated vector and partially abrogated with a null-expressing adenoviral vector. Similarly, combined bleomycin/adenoviral vector administration caused a 2-fold increase in the increment of lung collagen (hydroxyproline) compared with bleomycin alone (150 ± 18 μg/animal vs 300 ± 22 μg/animal; n = 5/group), which was abrogated by substituting a UV-inactivated, or a null-expressing adenoviral vector. Neither IT adenoviral vectors alone nor IT saline alone induced lung fibrosis (by hydroxyproline and trichrome stain). Combined bleomycin/adenoviral vector administration also resulted in increased inflammation (2-fold increment in total BAL cells), and alveolar protein levels compared with bleomycin alone, at 10 days after IT bleomycin. Adenoviral vectors alone had no effect on BAL cell counts or protein levels compared with IT saline-administered controls. The alveolar lymphocytosis was also 2-fold higher in the bleomycin/adenovirally administered group compared with the bleomycin alone group. These data indicate that adenoviral vectors are proinflammatory, enhance lymphocytic recruitment into the alveolar compartment and profibrotic. Further, the dependence of these effects on viral/foreign gene expression implicate antiviral adaptive immunity. Viral-induced adaptive immunity may be one mechanism whereby viral infection will induce a fibrotic response in susceptible hosts with underlying lung inflammation.

Adenovirus-mediated Overexpression of FcγRIIB Attenuates Pulmonary Inflammation and Fibrosis

Abnormal expression of IGF-binding proteins, an initiating event in idiopathic pulmonary fibrosis?

FcεRI deficiency alleviates silica-induced pulmonary inflammation and fibrosis

CCL17 Drives Fibroblast Activation in the Progression of Pulmonary Fibrosis by Enhancing the TGF-β/Smad Signaling.

The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis

MCPIP1 Regulates Alveolar Macrophage Apoptosis and Pulmonary Fibroblast Activation after in Vitro Exposure to Silica.

Modulation of pulmonary fibrosis by IL-13Rα2

AAV9-HGF Cooperating with TGF-beta/Smad Inhibitor Attenuates Silicosis Fibrosis Via Inhibiting Ferroptosis

PD-1/PD-L1 inhibitor ameliorates silica-induced pulmonary fibrosis by maintaining systemic immune homeostasis

Stimulator of Interferon Genes Deficiency in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Role of Human Pulmonary Fibroblast-Derived MCP-1 in Cell Activation and Migration in Experimental Silicosis.

ZC3H4 regulates infiltrating monocytes, attenuating pulmonary fibrosis through IL-10

Transcriptomic profiling of lung fibroblasts in silicosis: Regulatory roles of Nrf2 agonists in a mouse model

The FMS-like tyrosine kinase-3 ligand/lung dendritic cell axis contributes to regulation of pulmonary fibrosis

Adenovirus is Profibrotic in Bleomycin-Induced Lung Injury in Mice Through Effects on Adaptive Immunity.

Mir-542-5p Attenuates Fibroblast Activation by Targeting Integrin Α6 in Silica-Induced Pulmonary Fibrosis

Exuberant fibroblast activity compromises lung function via ADAMTS4

Interleukin-19 Aggravates Pulmonary Fibrosis via Activating Fibroblast through TGF-β/Smad Pathway

Lysophosphatidylcholine acyltransferase 1 alleviates silica-induced pulmonary fibrosis by modulating lipid metabolism

Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis

Quercetin Alleviates Pulmonary Fibrosis in Silicotic Mice by Inhibiting Macrophage Transition and TGF-β-Smad2/3 Pathway